Brokerages forecast that Walgreens Boots Alliance, Inc. (NASDAQ:WBA) will report $1.22 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have issued estimates for Walgreens Boots Alliance’s earnings, with the highest EPS estimate coming in at $1.25 and the lowest estimate coming in at $1.18. Walgreens Boots Alliance reported earnings per share of $1.07 during the same quarter last year, which would indicate a positive year-over-year growth rate of 14%. The company is expected to issue its next quarterly earnings report before the market opens on Wednesday, October 25th.

According to Zacks, analysts expect that Walgreens Boots Alliance will report full-year earnings of $5.02 per share for the current year, with EPS estimates ranging from $4.98 to $5.07. For the next year, analysts anticipate that the business will report earnings of $5.54 per share, with EPS estimates ranging from $5.38 to $5.70. Zacks’ earnings per share averages are an average based on a survey of analysts that that provide coverage for Walgreens Boots Alliance.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, topping the consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The company had revenue of $30.12 billion during the quarter, compared to the consensus estimate of $29.72 billion. During the same period in the previous year, the firm posted $1.18 earnings per share. The firm’s revenue for the quarter was up 2.1% on a year-over-year basis.

Several research analysts recently issued reports on the stock. Needham & Company LLC set a $94.00 price target on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Monday, July 17th. Credit Suisse Group reissued a “buy” rating and set a $97.00 price objective on shares of Walgreens Boots Alliance in a research note on Thursday, July 13th. Leerink Swann set a $86.00 price objective on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Friday, July 7th. Citigroup Inc. restated a “buy” rating on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. Finally, Guggenheim restated a “buy” rating on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $92.06.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total transaction of $218,305.44. Following the completion of the sale, the director now directly owns 19,151 shares in the company, valued at approximately $1,528,058.29. The sale was disclosed in a document filed with the SEC, which is available through this link. Insiders own 13.50% of the company’s stock.

Large investors have recently made changes to their positions in the business. Franklin Resources Inc. increased its position in shares of Walgreens Boots Alliance by 24.7% during the 2nd quarter. Franklin Resources Inc. now owns 18,502,701 shares of the pharmacy operator’s stock valued at $1,448,939,000 after purchasing an additional 3,662,302 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in shares of Walgreens Boots Alliance by 471.4% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,295,583 shares of the pharmacy operator’s stock worth $258,077,000 after purchasing an additional 2,718,800 shares during the period. Vanguard Group Inc. lifted its stake in shares of Walgreens Boots Alliance by 2.8% in the 2nd quarter. Vanguard Group Inc. now owns 69,985,653 shares of the pharmacy operator’s stock worth $5,480,577,000 after purchasing an additional 1,926,108 shares during the period. Nordea Investment Management AB lifted its stake in shares of Walgreens Boots Alliance by 26.5% in the 1st quarter. Nordea Investment Management AB now owns 9,154,328 shares of the pharmacy operator’s stock worth $760,267,000 after purchasing an additional 1,917,082 shares during the period. Finally, Wellington Management Group LLP lifted its stake in shares of Walgreens Boots Alliance by 5.9% in the 1st quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator’s stock worth $2,727,932,000 after purchasing an additional 1,824,300 shares during the period. 60.16% of the stock is currently owned by institutional investors and hedge funds.

WARNING: “Walgreens Boots Alliance, Inc. (WBA) Expected to Post Earnings of $1.22 Per Share” was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/walgreens-boots-alliance-inc-wba-expected-to-post-earnings-of-1-22-per-share/1603777.html.

Walgreens Boots Alliance (NASDAQ WBA) traded down 0.80% during midday trading on Monday, hitting $76.60. 5,241,298 shares of the company were exchanged. The firm has a market capitalization of $81.97 billion, a PE ratio of 19.34 and a beta of 1.25. Walgreens Boots Alliance has a 1-year low of $75.18 and a 1-year high of $89.69. The stock has a 50 day moving average of $81.36 and a 200 day moving average of $81.86.

Walgreens Boots Alliance announced that its board has approved a share repurchase program on Thursday, June 29th that authorizes the company to repurchase $5.00 billion in shares. This repurchase authorization authorizes the pharmacy operator to buy up to 5.9% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company’s management believes its stock is undervalued.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 12th. Investors of record on Friday, August 18th were given a dividend of $0.40 per share. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. The ex-dividend date was Wednesday, August 16th. This represents a $1.60 dividend on an annualized basis and a yield of 2.09%. Walgreens Boots Alliance’s dividend payout ratio is 40.30%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Get a free copy of the Zacks research report on Walgreens Boots Alliance (WBA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.